Surely the second half un-audited update is pointing to the fact that OCL has delivered in the second half. First half revenue 19mill NPAT 0.6 to 0.8. Year end revenue 41mill approx NPAT 3.8mill and that is without any input from ECM. Was there a lot of expenditure in the first half. Not a holder. Just come across this Company so don't know much.
RAB
- Forums
- ASX - By Stock
- OCL
- any following this little beauty?
any following this little beauty?, page-17
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.52 |
Change
0.200(1.15%) |
Mkt cap ! $1.408B |
Open | High | Low | Value | Volume |
$17.38 | $17.70 | $17.38 | $1.311M | 74.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124 | $17.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.66 | 737 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7125 | 2.750 |
2 | 1356 | 2.710 |
2 | 1194 | 2.600 |
1 | 2997 | 2.510 |
2 | 44658 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 3 | 1 |
2.790 | 3 | 1 |
2.800 | 5003 | 2 |
2.850 | 2206 | 1 |
2.950 | 354 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
OCL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online